Ambit Biosciences Corp
AMBI
AMBI was delisted on the 10th of November, 2014.
49 hedge funds and large institutions have $154M invested in Ambit Biosciences Corp in 2014 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 11 closing their positions.
129% more capital invested
Capital invested by funds: $67M → $154M (+$86.5M)
118% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 11
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
80% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 5
36% more funds holding
Funds holding: 36 → 49 (+13)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$2.37M |
| 2 |
U
UBS
Zurich,
Switzerland
|
+$1.27M |
| 3 |
GP
GLG Partners
London,
United Kingdom
|
+$1.24M |
| 4 |
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Harrisburg,
Pennsylvania
|
+$1.19M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$1.11M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$3.12M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.75M |
| 3 |
WC
Wexford Capital
West Palm Beach,
Florida
|
-$2.28M |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.92M |
| 5 |
AG
Artal Group
Luxembourg
|
-$1.73M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SFM
51
Sphera Funds Management
Tel Aviv,
Israel
| – | -$1.92M | -277,568 | Closed |
|
|
AG
52
Artal Group
Luxembourg
| – | -$1.73M | -250,000 | Closed |
|
|
EAM
53
Eventide Asset Management
Boston,
Massachusetts
| – | -$1.04M | -151,100 | Closed |
|
|
BIT
54
BlackRock Institutional Trust
San Francisco,
California
| – | -$689K | -99,732 | Closed |
|
|
DCM
55
Driehaus Capital Management
Chicago,
Illinois
| – | -$276K | -40,000 | Closed |
|
|
NI
56
Numeric Investors
Boston,
Massachusetts
| – | -$243K | -35,131 | Closed |
|
57
Two Sigma Investments
New York
| – | -$150K | -21,673 | Closed |
|
|
BJ
58
BlackRock Japan
Tokyo,
Japan
| – | -$30K | -4,376 | Closed |
|
|
GSC
59
Ground Swell Capital
Folly Beach,
South Carolina
| – | -$1K | -167 | Closed |
|
AMBI Hedge Fund Activity: Q3 2014 in Review
49 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Ambit Biosciences Corp (AMBI) for Q3 2014, worth a combined $154M — up 129% from $67M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new AMBI positions and 11 closed out — a net gain of 13 holders — while 9 added to existing stakes and 5 trimmed.
The largest buyer was Baker Bros. Advisors, adding an estimated $2.37M. The largest seller was Great Point Partners, cutting an estimated $3.12M.
- 49 institutional investors held Ambit Biosciences Corp (AMBI) as of Q3 2014, up from 36 in Q2 2014.
- Funds reported $154M of Ambit Biosciences Corp stock for Q3 2014, up 129% quarter-over-quarter.
- 24 funds opened new Ambit Biosciences Corp positions in Q3 2014 and 11 closed out, a net change of +13 holders.
- The largest Ambit Biosciences Corp buyer in Q3 2014 was Baker Bros. Advisors, an estimated $2.37M added.
- The largest Ambit Biosciences Corp seller in Q3 2014 was Great Point Partners, an estimated $3.12M sold.
Based on aggregated 13F filings for Q3 2014.